Position in LH
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$324,800
+$7,564 QoQ
Shares Held
1,160
-2.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#686
of 1,040 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Ballentine Partners, LLC holds $12,975,489 across 11 Diagnostics & Research names. LH ranks #10 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
7,469 | $3,744,655 | |
| 2 | DHR |
Danaher Corp /De/
|
14,159 | $2,697,004 | |
| 3 | ILMN |
Illumina, Inc.
|
12,679 | $2,229,347 | |
| 4 | WAT |
Waters Corp /De/
|
2,310 | $866,340 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
1,362 | $717,010 | |
| 6 | DGX |
Quest Diagnostics Inc
|
3,058 | $648,142 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
495 | $632,365 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
2,177 | $420,639 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $324,800 | 1,160 | Shares | Other | 2026-07-17 | |
| 2026-03-31 | $317,236 | 1,189 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $288,511 | 1,150 | Shares | Other | 2026-02-03 | |
| 2025-09-30 | $345,906 | 1,205 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $325,511 | 1,240 | Shares | Other | 2025-07-15 | |
| 2025-03-31 | $266,254 | 1,144 | Shares | Other | 2025-05-01 | |
| 2024-12-31 | $259,819 | 1,133 | Shares | Other | 2025-01-16 | |
| 2024-09-30 | $248,509 | 1,112 | Shares | Other | 2024-10-23 | |
| No filing history on record for this holder in this stock. | ||||||